Keros Therapeutics, INC 8-K filings

Keros Therapeutics' CEO, Jasbir Seehra, will participate in a fireside chat at the Leerink Partners 2024 Global Biopharma Conference on March 12, 2024.

Keros Therapeutics announces the resignation of its Chief Medical Officer, Simon Cooper, effective March 12, 2024, as the company initiates a search for his replacement.

Keros Therapeutics announced its fourth quarter and full year 2023 financial results, highlighting clinical progress and a strengthened cash position.